Approval of the First Nonprescription Oral Contraceptive Pill.
J Obstet Gynecol Neonatal Nurs
; 53(5): 464-476, 2024 Sep.
Article
em En
| MEDLINE
| ID: mdl-39153740
ABSTRACT
In July 2023, the U.S. Food and Drug Administration approved Opill (norgestrel 0.075 mg), a progestin-only tablet to prevent pregnancy to be used without a prescription. Although progestin-only birth control pills were approved in 1973, it has taken 50 years for the first oral contraceptive pills to be sold over the counter. In this column, I review the evidence on the barriers to access oral contraceptive pills, the efficacy, preferences and support of a nonprescription progestin-only pill, the cost, and policy implications for health insurance coverage. I conclude with recommendations from professional organizations on over-the-counter access to hormonal contraception.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Medicamentos sem Prescrição
Limite:
Female
/
Humans
/
Pregnancy
País/Região como assunto:
America do norte
Idioma:
En
Revista:
J Obstet Gynecol Neonatal Nurs
Assunto da revista:
ENFERMAGEM
/
GINECOLOGIA
/
OBSTETRICIA
/
PERINATOLOGIA
Ano de publicação:
2024
Tipo de documento:
Article
País de publicação:
Estados Unidos